Oruka’s ORKA-001 Shows 100-Day Half-Life, Paving W...
Category : Clinical Trial Update 19 September 2025Oruka Therapeutics has shared interim Phase 1 data for ORKA-001, a long-acting IL-23p19 antibody, at...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
MapLight Launches Phase 2 Study of Novel M1/M4 Ago...
Category : Clinical Trial Update 19 September 2025MapLight Therapeutics has initiated the Phase 2 VISTA study of ML-007C-MA, its investigational M1/M4...
AstraZeneca’s Phase III RESOLUTE Trial of Fasenra...
Category : Clinical Trial Update 19 September 2025AstraZeneca announced results from the RESOLUTE phase III trial of its biologic Fasenra (benralizuma...
AstraZeneca’s Saphnelo Hits Key Milestone in Subcu...
Category : Clinical Trial Update 18 September 2025AstraZeneca announced positive interim results from the phase III TULIP-SC trial of Saphnelo (anifro...
CorestemChemon Presents Phase 3 ALSummit Trial Res...
Category : Clinical Trial Update 18 September 2025CorestemChemon Inc. (KOSDAQ: 166480) presented results from the Phase 3 ALSummit trial of Neuronata-...
Latest Newsletter Post
-
AstraZeneca’s Phase III RESOLUTE Tr..
19 September 2025
-
MapLight Launches Phase 2 Study of..
19 September 2025
-
Oruka’s ORKA-001 Shows 100-Day Half..
19 September 2025
-
MagicRNA Publishes First Clinical D..
18 September 2025
-
Ascletis Presents Phase III Results..
18 September 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com